View Item 

Show simple item record

Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between by immunofluorescence and multiplex assays
dc.contributor.authorSomers, Emily C.
dc.contributor.authorMonrad, SU
dc.contributor.authorWarren, J
dc.contributor.authorSolano, M
dc.contributor.authorSchnaas, L
dc.contributor.authorHernandez-Avila, M
dc.contributor.authorTellez-Rojo, MM
dc.contributor.authorHu, H
dc.date.accessioned2017-06-09T17:30:59Z
dc.date.available2017-06-09T17:30:59Z
dc.date.issued2016
dc.identifier.citationSomers EC, Monrad SU, Warren J, Solano M, Schnaas L, Hernandez-Avila M, Tellez-Rojo MM, Hu H. Antinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between by immunofluorescence and multiplex assays. Clin Epidemiol Clin Epidemiol 2017;(9):1-8. PM28053555; PMCID: PMC5192054
dc.identifier.urihttps://hdl.handle.net/2027.42/136906
dc.publisherDove Medical Press
dc.titleAntinuclear antibody prevalence in a general pediatric cohort from Mexico City: discordance between by immunofluorescence and multiplex assays
dc.typeArticle
dc.subject.hlbsecondlevelInternal Medicine and Specialties
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumRheumatology, Division of
dc.contributor.affiliationumcampusAnn Arbor
dc.identifier.pmid28053555
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/136906/1/26.AntinuclearantibodyprevalenceMexicoCity.pdf
dc.identifier.sourceClinical Epidemiology
dc.owningcollnameRheumatology, Division of


Files in this item

Name:
26.Antinuclearantibodyprevalen ...
Size:
1.585MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.